News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
2,914 Results
Type
Article (26)
Press Release (2888)
Section
Business (1333)
Career Advice (2)
Deals (180)
Drug Development (631)
FDA (95)
Job Trends (267)
News (2103)
Policy (116)
Tag
Academia (3)
Alliances (41)
Alzheimer's disease (27)
Approvals (100)
Artificial intelligence (1)
Bankruptcy (1)
Best Places to Work (294)
Breast cancer (4)
Cancer (33)
Career advice (1)
Clinical research (610)
Collaboration (4)
Compensation (1)
COVID-19 (4)
Data (49)
Diabetes (1)
Diagnostics (19)
Earnings (1346)
Events (319)
FDA (109)
Frontotemporal dementia (1)
Funding (1)
Generative AI (1)
Gene therapy (3)
GLP-1 (8)
Government (8)
Healthcare (85)
Infectious disease (4)
Inflammatory bowel disease (2)
IPO (160)
Job creations (1)
Job search strategy (1)
Kidney cancer (1)
Layoffs (1)
Legal (1)
Lung cancer (13)
Lymphoma (6)
Manufacturing (1)
MASH (1)
Medical device (56)
Medtech (56)
Mergers & acquisitions (23)
Metabolic disorders (3)
Multiple sclerosis (2)
NASH (1)
Neuroscience (33)
NextGen Class of 2024 (9)
Non-profit (4)
Northern California (22)
Obesity (1)
Parkinson's disease (1)
People (8)
Phase I (94)
Phase II (187)
Phase III (356)
Pipeline (23)
Postmarket research (27)
Preclinical (11)
Prostate cancer (2)
Radiopharmaceuticals (6)
Rare diseases (3)
Regulatory (127)
Reports (2)
Research institute (6)
Resumes & cover letters (1)
Schizophrenia (2)
Southern California (8)
Startups (3)
United States (167)
Vaccines (2)
Date
Today (2)
Last 7 days (5)
Last 30 days (36)
Last 365 days (419)
2024 (416)
2023 (423)
2022 (418)
2021 (481)
2020 (310)
2019 (202)
2018 (150)
2017 (116)
2016 (39)
2015 (73)
2014 (43)
2013 (25)
2012 (28)
2011 (23)
2010 (22)
Location
Asia (322)
Australia (12)
California (31)
Canada (9)
China (4)
Delaware (10)
Europe (576)
Florida (5)
Georgia (2)
Illinois (1)
Indiana (13)
Japan (5)
Maryland (6)
Massachusetts (24)
Minnesota (1)
New Jersey (28)
New York (18)
North Carolina (6)
Northern California (22)
Ohio (2)
Pennsylvania (14)
South America (5)
Southern California (8)
Texas (3)
Utah (4)
Washington State (2)
2,914 Results for "%E2%80%9D%20target=".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enterome to Host Webinar on New Clinical Data From the Ongoing Phase 1/2 ‘SIDNEY’ Trial of Lead Programme, EO2463
November 13, 2024
·
4 min read
Press Releases
Hidden Fat Predicts Alzheimer’s 20 Years Ahead of Symptoms
December 2, 2024
·
5 min read
Press Releases
Almirall’s Nine-Month 2024 Results: Almirall Reports Strong Performance at Q3 2024 - Driven by Successful Commercial Execution of the Dermatology Portfolio, Fuelled by Biologics Growth
November 11, 2024
·
7 min read
Press Releases
New and updated data for Roche’s fixed-duration Columvi and Lunsumio at ASH 2024 reinforce their potential to improve outcomes for people with lymphoma
December 10, 2024
·
12 min read
Press Releases
Vertex Reports Third Quarter 2024 Financial Results
November 4, 2024
·
19 min read
Press Releases
Lilly’s Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as Monotherapy and in Combination with Verzenio® (abemaciclib) in Patients with ER+, HER2- Advanced Breast Cancer
December 11, 2024
·
26 min read
Press Releases
Arrowhead Pharmaceuticals Launches New Disease Awareness Campaign, ‘We’ll Get There Soon,’ to Inspire Hope for the Rare Disease Community Affected by Familial Chylomicronemia Syndrome
November 4, 2024
·
6 min read
Press Releases
S.BIOMEDICS Investigational Cell Therapy for Parkinson’s Disease With TED-A9 Shows Positive Data at 12-months in Phase 1/2a Clinical Trial
November 26, 2024
·
5 min read
Press Releases
Datopotamab Deruxtecan Demonstrated Meaningful Clinical Activity in Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer in TROPION-Lung05 and TROPION-Lung01 Pooled Analysis
December 6, 2024
·
11 min read
Press Releases
Longer-term data for Novartis Scemblix® reinforce superior efficacy with favorable safety and tolerability profile in adults with newly diagnosed CML
December 9, 2024
·
15 min read
1 of 292
Next
